Repair of acute respiratory distress syndrome by stromal cell administration (REALIST): a structured study protocol for an open-label dose-escalation phase 1 trial followed by a randomised, triple-blind, allocation concealed, placebo-controlled phase 2 trial. (2022)
Attributed to:
A GMP cell therapy facility to test cell based therapies
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s13063-022-06220-0
PubMed Identifier: 35562778
Publication URI: http://europepmc.org/abstract/MED/35562778
Type: Journal Article/Review
Volume: 23
Parent Publication: Trials
Issue: 1
ISSN: 1745-6215